Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Pregabalin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    136 result(s) found for: Pregabalin. Displaying page 1 of 7.
    1  2  3  4  5  6  7  Next»
    EudraCT Number: 2010-023263-18 Sponsor Protocol Number: A0081105 Start Date*: 2013-06-12
    Sponsor Name:Pfizer Inc 235 East 42nd Street, New York, NY10017 US
    Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER TRIAL OF PREGABALIN AS ADJUNCTIVE THERAPY IN PEDIATRIC AND ADULT SUBJECTS WITH PRIMARY GENERALIZED TONIC-CLONIC SEIZURES
    Medical condition: Primary Generalised Tonic Clonic Seizures
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004852 10018101 Generalised tonic-clonic seizures HLT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: CZ (Completed) GB (Completed) HU (Completed) LT (Completed) NL (Completed) SK (Completed) AT (Completed) BG (Completed) ES (Completed) PL (Completed) EE (Completed) GR (Completed) BE (Completed) HR (Completed) DK (Completed) PT (Not Authorised) DE (Completed)
    Trial results: View results
    EudraCT Number: 2011-001412-65 Sponsor Protocol Number: A0081106 Start Date*: 2012-01-25
    Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, NY 10017
    Full Title: A 12-MONTH OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF PREGABALIN AS ADJUNCTIVE THERAPY IN PEDIATRIC SUBJECTS 1 MONTH TO 16 YEARS OF AGE WITH PARTIAL ONSET SEIZURES AND PEDIATRIC AN...
    Medical condition: Partial onset seizures and Primary Generalised Tonic Clonic Seizures
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004852 10034089 Partial seizures NOS LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: HU (Completed) CZ (Completed) PL (Completed) EE (Completed) SE (Completed) BE (Completed) FR (Completed) IT (Completed) BG (Completed) GR (Completed) NL (Completed) LT (Completed) FI (Completed) AT (Completed) SK (Completed) ES (Completed) GB (Completed) DE (Completed) HR (Completed) PT (Not Authorised) DK (Completed)
    Trial results: View results
    EudraCT Number: 2005-004074-24 Sponsor Protocol Number: PGB04/2005 Start Date*: 2006-02-03
    Sponsor Name:Gesellschaft für Epilepsieforschung e.V.
    Full Title: Effectiveness and safety of pregabalin in patients with epilepsy and anxiety disorder.
    Medical condition: Focal epilepsy, anxiety disorder
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-001439-37 Sponsor Protocol Number: MACSevoPregabalin Start Date*: 2019-09-16
    Sponsor Name:Medical University of Vienna, Department of Anaesthesia, General Critical Care and Pain Management
    Full Title: The effect of pregabalin on the minimal alveolar concentration of sevoflurane
    Medical condition: This study aims to investigate the effect of clinically used doses of Pregabalin on the minimum alveolar concentration of sevoflurane to provide more information to clinicians using this adjunctive...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2004-000954-22 Sponsor Protocol Number: CI-1008-100 Start Date*: 2004-09-23
    Sponsor Name:Pfizer Global Research & Development
    Full Title: A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders
    Medical condition: Generalized Anxiety Disorder
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2006-002890-31 Sponsor Protocol Number: Pregab1 Start Date*: 2006-08-25
    Sponsor Name:Dept. of Anaesthesia, Medical University of Vienna
    Full Title: Does Pregabalin reduce preoperative anxiety: a placebo controlled study
    Medical condition: Patients should receive Pregabalin or placebo as premedication one hour before ambulatory elective surgery. After this they have to assess their anxiety and pain with Visual Analog Scale (VAS) for ...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2012-003304-12 Sponsor Protocol Number: A0081279 Start Date*: 2013-02-12
    Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017
    Full Title: A Randomized Double Blind Placebo Controlled Parallel Group Study of the Efficacy and Safety of Pregabalin (BID) in Subjects with Post-Traumatic Peripheral Neuropathic Pain
    Medical condition: Chronic post-traumatic peripheral neuropathic pain
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004852 10054095 Neuropathic pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) DK (Completed) BG (Completed) HU (Completed) BE (Completed) HR (Completed)
    Trial results: View results
    EudraCT Number: 2011-005872-41 Sponsor Protocol Number: QTZ-EC-0004 Start Date*: 2012-04-25
    Sponsor Name:Astellas Pharma Europe Ltd.
    Full Title: QUTENZA versus pregabalin in subjects with peripheral neuropathic pain: an open-label, randomized, multicenter, noninferiority efficacy and tolerability study
    Medical condition: Patients who have a documented diagnosis of probable or definite Peripheral Neuropathic Pain
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004852 10054095 Neuropathic pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) CZ (Completed) FI (Completed) AT (Completed) SK (Completed) ES (Completed) BE (Completed) SI (Completed) GB (Completed) DE (Completed) GR (Completed) PT (Completed) IT (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2005-002130-35 Sponsor Protocol Number: GARBO-2005-02 Start Date*: 2005-09-15
    Sponsor Name:INSTITUTO DE ESTUDIOS DEL SISTEMA NERVIOSO
    Full Title: A Multicenter, Randomized, Parallel groups, Double-Blind, Placebo-controlled and 12 weeks follow-up Study to Evaluate the Safety, Tolerability and Efficacy of Pregabalin in Idiopathic Restless Legs...
    Medical condition: Idiopathic Restless legs Syndrome
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-004201-26 Sponsor Protocol Number: NC200602 Start Date*: 2007-03-15
    Sponsor Name:Neuro-Consil GmbH
    Full Title: Efficacy and tolerability of flexible dose adjusted pregabalin as first-line add-on treatment of patients with focal seizures
    Medical condition: epilepsis with seizures of focal origin
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-011384-36 Sponsor Protocol Number: Studio Pregabalin Start Date*: 2009-09-22
    Sponsor Name:ISTITUTO GIANNINA GASLINI
    Full Title: Randomized, controlled, trial, phase III, pregabalin vs placebo on postoperative morphine request after pectus escavatum surgery in children
    Medical condition: Acute pain management
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-004397-28 Sponsor Protocol Number: PANPAIN/1 Start Date*: 2012-01-25
    Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de salut MAR)
    Full Title: Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study.
    Medical condition: Pancreatic cancer induced abdominal pain
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004134-16 Sponsor Protocol Number: Start Date*: 2008-02-11
    Sponsor Name:Charité Universitätsmedizin Berlin
    Full Title: Effectiveness and Safety of Pregabalin (Lyrica) in treatment of in-patients with ethanol withdrawal syndrom
    Medical condition: Patients with alcohol dependence in withdrawal states.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-005555-17 Sponsor Protocol Number: A6061021 Start Date*: 2006-09-04
    Sponsor Name:Pfizer AB
    Full Title: [S,S]-REBOXETINE ADD-ON TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER TRIAL OF [S,S]-REBOXETINE IN PATIENTS WITH POSTHERPETIC NEURALGIA (PHN) CONCOMITANTLY TREATED WITH PREGAB...
    Medical condition: Postherpetic Neuralgia`
    Disease: Version SOC Term Classification Code Term Level
    8.1 10029223 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended) DE (Prematurely Ended) GB (Completed) ES (Completed) NL (Completed) CZ (Completed) IT (Prematurely Ended) AT (Prematurely Ended) LV (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-000955-40 Sponsor Protocol Number: CI-1008-152 Start Date*: 2004-09-23
    Sponsor Name:Pfizer Global Research & Development
    Full Title: A Placebo-Controlled Study of Pregabalin in Elderly Patients With Generalized Anxiety Disorder
    Medical condition: Generalized Anxiety Disorder
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2004-004953-24 Sponsor Protocol Number: 20041202 Start Date*: 2005-07-20
    Sponsor Name:Department of Anesthesiology, University Hospital Erlangen
    Full Title: A double-blind placebo-controlled two period crossover study of pregabalin and aprepitant in the electrical hyperalgesia model of central sensitisation in healthy volunteers
    Medical condition: The primary aim of the present study is therefore to investigate the effects of oral pregabalin and aprepitant on experimentally-induced central sensitization in the electrical hyperalgesia model, ...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-020852-79 Sponsor Protocol Number: A0081041 Start Date*: 2011-08-24
    Sponsor Name:Pfizer Inc.235 East 42nd Street, New York, NY 10017
    Full Title: A DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF PREGABALIN AS ADJUNCTIVE THERAPY IN CHILDREN 4 -16 YEARS OF AGE WITH PARTIAL ONSET SEIZURES
    Medical condition: Partial onset seizures
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004852 10034089 Partial seizures NOS LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: CZ (Completed) LT (Prematurely Ended) FI (Completed) NL (Completed) FR (Ongoing) HU (Completed) BE (Completed) EE (Completed) SE (Completed) PL (Completed) AT (Completed) GR (Completed) IT (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2009-017728-13 Sponsor Protocol Number: globuspregabalin Start Date*: 2010-02-18
    Sponsor Name:UZLeuven
    Full Title: A randomized controlled trial comparing pregabalin and placebo in patients with persistent globus sensation
    Medical condition: Globus symptoms
    Disease: Version SOC Term Classification Code Term Level
    12.1 10051180 Globus feeling in pharynx LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2004-002948-10 Sponsor Protocol Number: A0081007 Start Date*: 2005-07-14
    Sponsor Name:Pfizer AB
    Full Title: A Randomised Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects with Neuropathic Pain Associated with Lumbo-sacral Radiculopathy (protocol dates 2004-11...
    Medical condition: Pain associated with lumbo-sacral radiculopathy
    Disease: Version SOC Term Classification Code Term Level
    7.0 10050085 VTc
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2011-005972-41 Sponsor Protocol Number: A9001464 Start Date*: 2012-08-22
    Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, NY 10017
    Full Title: A PHASE 4 MULTICENTER, OPEN-LABEL, PILOT STUDY OF PREGABALIN AND PREDICTION OF TREATMENT RESPONSE IN PATIENTS WITH POSTHERPETIC NEURALGIA.
    Medical condition: Postherpetic Neuralgia (PHN)
    Disease: Version SOC Term Classification Code Term Level
    15.1 100000004852 10034911 PHN LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended) ES (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 01:45:39 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA